Boston, MA, United States of America

Federica Casati

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Continuus Pharmaceuticals, Inc., I.m.a. Industria Macchine Automatiche S.p.a.. Active years: 2026.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Federica Casati: Innovator in Pharmaceutical Manufacturing

Introduction

Federica Casati is a prominent inventor based in Boston, MA, known for her contributions to the pharmaceutical manufacturing industry. With a focus on innovative technologies, she has developed solutions that enhance the efficiency and effectiveness of drug production.

Latest Patents

Federica holds a patent for a "System for molding and coating of pharmaceutical tablets." This invention discloses new injection molding-coating devices designed for the continuous manufacturing of coated pharmaceutical tablets. These devices incorporate one or more active pharmaceutical ingredients and excipients, providing significant advancements in the pharmaceutical and drug manufacturing sectors.

Career Highlights

Throughout her career, Federica has worked with notable companies, including Continuus Pharmaceuticals, Inc. and I.M.A. Industria Macchine Automatiche S.P.A. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical technologies and contribute to groundbreaking innovations.

Collaborations

Federica has collaborated with talented individuals in her field, including Saptarshi Chattopadhyay and Evan James Goodwin. These partnerships have fostered a creative environment that encourages the development of new ideas and solutions.

Conclusion

Federica Casati's work in the pharmaceutical industry exemplifies the impact of innovation on drug manufacturing processes. Her patent and collaborations highlight her commitment to advancing technology in this critical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…